SYNLAB AG (SYAB.DE) Stock Price & Overview
FRA:SYAB • DE000A2TSL71
Current stock price
The current stock price of SYAB.DE is 11.06 EUR. Today SYAB.DE is down by -0.18%. In the past month the price decreased by -0.18%. In the past year, price increased by 23.37%.
SYAB.DE Key Statistics
- Market Cap
- 2.431B
- P/E
- 27.65
- Fwd P/E
- 30.12
- EPS (TTM)
- 0.40
- Dividend Yield
- 2.91%
SYAB.DE Stock Performance
SYAB.DE Stock Chart
SYAB.DE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to SYAB.DE. When comparing the yearly performance of all stocks, SYAB.DE is one of the better performing stocks in the market, outperforming 77.92% of all stocks.
SYAB.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SYAB.DE. SYAB.DE has an average financial health and profitability rating.
SYAB.DE Earnings
SYAB.DE Forecast & Estimates
9 analysts have analysed SYAB.DE and the average price target is 13.6 EUR. This implies a price increase of 22.97% is expected in the next year compared to the current price of 11.06.
For the next year, analysts expect an EPS growth of -36.39% and a revenue growth 1.55% for SYAB.DE
SYAB.DE Groups
Sector & Classification
SYAB.DE Financial Highlights
Over the last trailing twelve months SYAB.DE reported a non-GAAP Earnings per Share(EPS) of 0.4. The EPS increased by 338.87% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.42% | ||
| ROA | 1.9% | ||
| ROE | 3.77% | ||
| Debt/Equity | 0.59 |
SYAB.DE Ownership
SYAB.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| FRE | FRESENIUS SE & CO KGAA | 12.07 | 25.177B | ||
| FME | FRESENIUS MEDICAL CARE AG | 9.8 | 11.836B | ||
| EUK | EUKEDOS SPA | N/A | 11.484M | ||
| V3V | FAMICORD AG | N/A |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About SYAB.DE
Company Profile
Synlab AG engages in the provision of clinical laboratory and medical diagnostic services. The company is headquartered in Muenchen, Bayern and currently employs 27,047 full-time employees. The company went IPO on 2021-04-30. The firm is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.
Company Info
IPO: 2021-04-30
SYNLAB AG
Moosacher Strasse 88
Muenchen BAYERN DE
Employees: 27047
Phone: 49893076020
SYNLAB AG / SYAB.DE FAQ
What does SYAB do?
Synlab AG engages in the provision of clinical laboratory and medical diagnostic services. The company is headquartered in Muenchen, Bayern and currently employs 27,047 full-time employees. The company went IPO on 2021-04-30. The firm is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.
Can you provide the latest stock price for SYNLAB AG?
The current stock price of SYAB.DE is 11.06 EUR. The price decreased by -0.18% in the last trading session.
What is the dividend status of SYNLAB AG?
SYNLAB AG (SYAB.DE) has a dividend yield of 2.91%. The yearly dividend amount is currently 0.35.
How is the ChartMill rating for SYNLAB AG?
SYAB.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the sector and industry classification for SYNLAB AG?
SYNLAB AG (SYAB.DE) operates in the Health Care sector and the Health Care Providers & Services industry.
What is the expected growth for SYAB stock?
The Revenue of SYNLAB AG (SYAB.DE) is expected to grow by 1.55% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.